Amylyx Pharmaceuticals Retirement Plan — Form 5500 plan (Amylyx Pharmaceuticals Inc.)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Amylyx Pharmaceuticals Retirement Plan is a benefit plan reported by Amylyx Pharmaceuticals Inc. under EIN 46-4600503 and plan number 001. The latest loaded filing year is 2023. The filing reports 226 participants and $18,502,622 in end-of-year plan assets, where available in the loaded dataset.
Key reported metrics
- Plan sponsor
- Amylyx Pharmaceuticals Inc.
- EIN
- 46-4600503
- Plan number
- 001
- Plan type
- 2
- Location
- Cambridge, MA
- Latest filing year
- 2023
How to read this plan profile
- Net assets = total assets minus total liabilities, end of year (Schedule H/I).
- Assets / participant is computed (assets ÷ reported participants) — a ratio, not a filed figure.
- Schedule chips (Sch H / I / C) show which schedules each filing includes.
- Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
- Figures are reported as filed, in whole dollars; verify against the official DOL/EBSA record before relying on them.
Form 5500 filing history
Each loaded annual filing for this plan. Open one for its full reported snapshot.
- 2023Sch HSch CView filing →
Reported financial statement
Reported figures as filed, in whole dollars. Only fields the filing reports are shown; others are marked not reported.
Full reported line items
Net assets
- Total assets (EOY)
- $18,502,622
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $18,502,622
- Net assets (BOY)
- $7,843,810
Income & contributions
- Employer contributions
- $2,068,444
- Participant contributions
- $4,884,287
- Total contributions
- $8,649,586
- Total income / additions
- $10,995,712
Expenses & distributions
- Benefits paid
- $310,629
- Administrative expenses
- $2,563
- Total expenses
- $336,900
- Net increase / (decrease)
- $10,658,812
Reported ratios
Derived only from this plan's own reported figures — comparisons within the filing, not benchmarks, estimates, or national averages.
Service provider compensation
Reported direct + indirect compensation per provider, ranked. Bars show relative scale.
- 1
- 2
Frequently asked questions
- Who sponsors the Amylyx Pharmaceuticals Retirement Plan?
- Amylyx Pharmaceuticals Retirement Plan is reported as sponsored by Amylyx Pharmaceuticals Inc. (EIN 46-4600503, plan number 001) in public Form 5500 filings.
- What is the most recent Form 5500 filing year for Amylyx Pharmaceuticals Retirement Plan?
- The latest Form 5500 filing year loaded for Amylyx Pharmaceuticals Retirement Plan is 2023.
- How many participants does Amylyx Pharmaceuticals Retirement Plan report?
- Amylyx Pharmaceuticals Retirement Plan reports 226 participants in its latest loaded Form 5500 filing.
- What are the reported plan assets for Amylyx Pharmaceuticals Retirement Plan?
- Amylyx Pharmaceuticals Retirement Plan reports $18,502,622 in end-of-year plan assets in its latest loaded Form 5500 filing.
Form 5500 terms, in plain English
- Form 5500
- The annual report most U.S. employee benefit plans file with the Department of Labor through the EFAST2 system. It documents the plan sponsor, participants, finances, and service-provider compensation.
- Schedule H
- The financial statement for larger plans (generally 100+ participants): assets, liabilities, net assets, income, expenses, and the net change.
- Schedule I
- The condensed financial statement for smaller plans, covering the same kinds of figures in less detail.
- Schedule C
- Reports compensation paid to the plan’s service providers — both direct and indirect.
- Net assets
- Total assets minus total liabilities at the end of the year — what the plan holds for participants.
- Employer / participant contributions
- Money contributed to the plan by the employer and by participants during the year.
Figures are reported as filed and may contain errors or omissions. Verify against the official DOL/EBSA record before relying on any value.